A Study of RAY1225 at Different Injection Sites in Participants With Different Body Sizes

NCT06577428 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: RAY1225

Sponsor

Guangdong Raynovent Biotech Co., Ltd